US Patent 11712472 Pharmaceutical composition comprising anti-human TSLP receptor antibody
Patent 11712472 was granted and assigned to Upstream Bio on August, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+433 characters)
US Patent 11712472 Pharmaceutical composition comprising anti-human TSLP receptor antibody
Article
Provided is a stable pharmaceutical composition, comprising an anti-human TSLP receptor antibody, capable of inhibiting the generation of chemically modified substances, such as deamidated forms and oxidized forms, or degradants or multimers. The pharmaceutical composition comprises an anti-human TSLP receptor antibody, a pharmaceutically acceptable buffer, arginine or a pharmaceutically acceptable salt thereof, and a surfactant.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
117124720
Date of Patent
August 1, 2023
0Patent Application Number
171724900
Date Filed
February 10, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11712472 Pharmaceutical composition comprising anti-human TSLP receptor antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
